| General Information of Drug Metabolite (DM) (ID: DM017308) |
| DM Name |
N-acetyl-batracylin
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
N-acetyltransferase 2 (NAT2)
|
DME0051
|
| Unclear - Unclear |
Daniquidone
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Daniquidone |
DR3104
|
Phase 1 |
Lymphoma |
|
|
| References |
| 1 |
Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
